Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-09-12 Sale |
2024-09-16 8:50 pm |
Mereo BioPharma Group plc | MREO | Scots-Knight Denise Chief Executive Officer |
88,657 | $4.3022 | $381,423 | 808,921 (Direct) |
View |
| 2024-09-12 Sale |
2024-09-16 8:49 pm |
Mereo BioPharma Group plc | MREO | Lewicki John A. Chief Scientific Officer |
16,149 | $4.3022 | $69,477 | 92,826 (Indirect Direct) |
View |
| 2024-09-12 Sale |
2024-09-16 8:48 pm |
Mereo BioPharma Group plc | MREO | Sermon Charles General Counsel |
30,926 | $4.3022 | $133,051 | 219,061 (Direct) |
View |
| 2024-09-12 Sale |
2024-09-16 8:47 pm |
Mereo BioPharma Group plc | MREO | Fox Christine Ann Chief Financial Officer |
28,286 | $4.3022 | $121,693 | 89,285 (Direct) |
View |
| 2024-09-12 Sale |
2024-09-16 8:46 pm |
Mereo BioPharma Group plc | MREO | Hughes-Wilson Alexandra See Remarks |
148,110 | $4.3022 | $637,203 | 50,475 (Direct) |
View |
| 2024-08-22 Sale |
2024-08-23 6:13 pm |
Mereo BioPharma Group plc | MREO | PAKIANATHAN DEEPIKA Director |
105,244 | $4.4298 | $466,210 | 30,000 (Direct) |
View |
| 2024-06-25 Sale |
2024-06-27 4:15 pm |
Mereo BioPharma Group plc | MREO | Sermon Charles General Counsel |
46,389 | $3.4853 | $161,678 | 184,387 (Direct) |
View |
| 2024-06-25 Sale |
2024-06-27 4:15 pm |
Mereo BioPharma Group plc | MREO | Lewicki John A. Chief Scientific Officer |
24,224 | $3.4853 | $84,427 | 62,975 (Indirect Direct) |
View |
| 2024-06-25 Sale |
2024-06-27 4:15 pm |
Mereo BioPharma Group plc | MREO | Fox Christine Ann Chief Financial Officer |
42,429 | $3.4853 | $147,876 | 57,571 (Direct) |
View |
| 2024-06-25 Sale |
2024-06-27 4:15 pm |
Mereo BioPharma Group plc | MREO | Scots-Knight Denise Chief Executive Officer |
132,985 | $3.4853 | $463,487 | 709,518 (Direct) |
View |
| 2024-06-25 Sale |
2024-06-27 4:15 pm |
Mereo BioPharma Group plc | MREO | Hughes-Wilson Alexandra See Remarks |
33,102 | $3.4853 | $115,369 | 34,548 (Direct) |
View |
| 2024-05-22 Sale |
2024-05-23 9:54 pm |
Mereo BioPharma Group plc | MREO | Hughes-Wilson Alexandra See Remarks |
100,432 | $2.9651 | $297,788 | 7,650 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-05 Option Award |
2025-02-06 4:30 pm |
N/A 2035-02-05 |
Mereo BioPharma Group plc | MREO | Yoskowitz Marc J Director |
68,719 | $0 | 68,719 (Direct) |
View |
| 2025-02-05 Option Award |
2025-02-06 4:30 pm |
N/A 2035-02-05 |
Mereo BioPharma Group plc | MREO | PAKIANATHAN DEEPIKA Director |
55,000 | $0 | 55,000 (Direct) |
View |
| 2025-02-05 Option Award |
2025-02-06 4:30 pm |
N/A 2035-02-05 |
Mereo BioPharma Group plc | MREO | Bender Jeremy Director |
71,768 | $0 | 71,768 (Direct) |
View |
| 2025-02-05 Option Award |
2025-02-06 4:30 pm |
N/A 2035-02-05 |
Mereo BioPharma Group plc | MREO | Ekblom Anders Director |
74,054 | $0 | 74,054 (Direct) |
View |
| 2025-02-05 Option Award |
2025-02-06 4:30 pm |
N/A 2035-02-05 |
Mereo BioPharma Group plc | MREO | Shames Daniel Director |
68,719 | $0 | 68,719 (Direct) |
View |
| 2025-02-05 Option Award |
2025-02-06 4:30 pm |
N/A 2035-02-05 |
Mereo BioPharma Group plc | MREO | WYZGA MICHAEL S Director |
85,487 | $0 | 85,487 (Direct) |
View |
| 2025-02-05 Option Award |
2025-02-06 4:30 pm |
N/A 2035-02-05 |
Mereo BioPharma Group plc | MREO | Jenkins Annalisa Director |
70,243 | $0 | 70,243 (Direct) |
View |
| 2025-02-05 Option Award |
2025-02-06 4:30 pm |
N/A 2035-02-05 |
Mereo BioPharma Group plc | MREO | Jacquet Pierre Director |
70,243 | $0 | 70,243 (Direct) |
View |
| 2025-01-25 Option Award |
2025-01-28 4:05 pm |
N/A 2035-01-25 |
Mereo BioPharma Group plc | MREO | Lewicki John A. Chief Scientific Officer |
116,000 | $0 | 116,000 (Direct) |
View |
| 2025-01-25 Option Award |
2025-01-28 4:05 pm |
N/A 2035-01-25 |
Mereo BioPharma Group plc | MREO | Fox Christine Ann Chief Financial Officer |
262,000 | $0 | 262,000 (Direct) |
View |
| 2025-01-25 Option Award |
2025-01-28 4:05 pm |
N/A 2035-01-25 |
Mereo BioPharma Group plc | MREO | Sermon Charles General Counsel |
262,000 | $0 | 262,000 (Direct) |
View |
| 2025-01-25 Option Award |
2025-01-28 4:05 pm |
N/A 2035-01-25 |
Mereo BioPharma Group plc | MREO | Hughes-Wilson Alexandra See Remarks |
154,000 | $0 | 154,000 (Direct) |
View |
| 2025-01-25 Option Award |
2025-01-28 4:05 pm |
N/A 2035-01-25 |
Mereo BioPharma Group plc | MREO | Scots-Knight Denise Chief Executive Officer |
825,000 | $0 | 825,000 (Direct) |
View |
| 2024-09-11 Exercise |
2024-09-13 4:57 pm |
2024-09-11 2025-01-25 |
Mereo BioPharma Group plc | MREO | Sermon Charles General Counsel |
65,600 | $0 | 249,987 (Direct) |
View |
| 2024-09-11 Exercise |
2024-09-13 4:50 pm |
2024-09-11 2025-01-25 |
Mereo BioPharma Group plc | MREO | Fox Christine Ann Chief Financial Officer |
60,000 | $0 | 117,571 (Direct) |
View |
| 2024-09-11 Exercise |
2024-09-13 4:49 pm |
2024-09-11 2025-01-25 |
Mereo BioPharma Group plc | MREO | Lewicki John A. Chief Scientific Officer |
46,000 | $0 | 108,975 (Direct) |
View |
| 2024-09-11 Exercise |
2024-09-13 4:49 pm |
2024-09-11 2025-01-25 |
Mereo BioPharma Group plc | MREO | Scots-Knight Denise Chief Executive Officer |
188,060 | $0 | 897,578 (Direct) |
View |
| 2024-09-11 Exercise |
2024-09-13 4:47 pm |
N/A 2033-01-25 |
Mereo BioPharma Group plc | MREO | Hughes-Wilson Alexandra See Remarks |
75,000 | $1.01 | 242,881 (Direct) |
View |
| 2024-09-11 Exercise |
2024-09-13 4:47 pm |
2024-09-11 2025-01-25 |
Mereo BioPharma Group plc | MREO | Hughes-Wilson Alexandra See Remarks |
40,000 | $0 | 242,881 (Direct) |
View |
| 2024-09-11 Exercise |
2024-09-13 4:47 pm |
N/A 2032-01-14 |
Mereo BioPharma Group plc | MREO | Hughes-Wilson Alexandra See Remarks |
93,333 | $1.4 | 242,881 (Direct) |
View |
| 2024-08-22 Exercise |
2024-08-23 6:13 pm |
N/A N/A |
Mereo BioPharma Group plc | MREO | PAKIANATHAN DEEPIKA Director |
2,071 | $3.87 | 30,000 (Direct) |
View |
| 2024-08-22 Exercise |
2024-08-23 6:13 pm |
N/A N/A |
Mereo BioPharma Group plc | MREO | PAKIANATHAN DEEPIKA Director |
1,825 | $3 | 30,000 (Direct) |
View |
| 2024-08-22 Exercise |
2024-08-23 6:13 pm |
N/A N/A |
Mereo BioPharma Group plc | MREO | PAKIANATHAN DEEPIKA Director |
6,492 | $1.84 | 30,000 (Direct) |
View |
| 2024-08-22 Exercise |
2024-08-23 6:13 pm |
N/A 2029-07-23 |
Mereo BioPharma Group plc | MREO | PAKIANATHAN DEEPIKA Director |
173,000 | $0 | 30,000 (Direct) |
View |
| 2024-08-22 Exercise |
2024-08-23 6:13 pm |
N/A N/A |
Mereo BioPharma Group plc | MREO | PAKIANATHAN DEEPIKA Director |
12,418 | $2.72 | 30,000 (Direct) |
View |
| 2024-08-22 Exercise |
2024-08-23 6:13 pm |
N/A N/A |
Mereo BioPharma Group plc | MREO | PAKIANATHAN DEEPIKA Director |
43,485 | $0.94 | 30,000 (Direct) |
View |
| 2024-08-22 Exercise |
2024-08-23 6:13 pm |
N/A N/A |
Mereo BioPharma Group plc | MREO | PAKIANATHAN DEEPIKA Director |
38,953 | $1.31 | 30,000 (Direct) |
View |
| 2024-06-21 Exercise |
2024-06-25 6:21 pm |
2024-06-21 2025-01-25 |
Mereo BioPharma Group plc | MREO | Lewicki John A. Chief Scientific Officer |
69,000 | $0 | 133,199 (Direct) |
View |
| 2024-06-21 Exercise |
2024-06-25 6:15 pm |
2024-06-21 2025-01-25 |
Mereo BioPharma Group plc | MREO | Scots-Knight Denise Chief Executive Officer |
282,090 | $0 | 1,030,563 (Direct) |
View |
| 2024-06-21 Exercise |
2024-06-25 6:14 pm |
2024-06-21 2025-01-25 |
Mereo BioPharma Group plc | MREO | Sermon Charles General Counsel |
98,400 | $0 | 296,376 (Direct) |
View |
| 2024-06-21 Exercise |
2024-06-25 6:13 pm |
2024-06-21 2025-01-25 |
Mereo BioPharma Group plc | MREO | Fox Christine Ann Chief Financial Officer |
90,000 | $0 | 160,000 (Direct) |
View |
| 2024-06-21 Exercise |
2024-06-25 6:13 pm |
2024-06-21 2025-01-25 |
Mereo BioPharma Group plc | MREO | Hughes-Wilson Alexandra See Remarks |
60,000 | $0 | 107,650 (Direct) |
View |
| 2024-06-17 Option Award |
2024-06-17 5:16 pm |
N/A N/A |
Mereo BioPharma Group plc | MREO | Rubric Capital Management LP Rosen David Efraim 10% Owner |
1,754,350 | $3.99 | 15,307,347 (Indirect) |
View |
| 2024-06-17 Option Award |
2024-06-17 4:15 pm |
N/A N/A |
Mereo BioPharma Group plc | MREO | WYZGA MICHAEL S Director |
25,050 | $3.99 | 25,050 (Direct) |
View |
| 2024-06-17 Option Award |
2024-06-17 4:15 pm |
N/A N/A |
Mereo BioPharma Group plc | MREO | Bender Jeremy Director |
12,550 | $3.99 | 12,550 (Indirect) |
View |
| 2024-05-22 Exercise |
2024-05-23 9:54 pm |
N/A 2033-01-25 |
Mereo BioPharma Group plc | MREO | Hughes-Wilson Alexandra See Remarks |
75,000 | $1.01 | 7,650 (Direct) |
View |
| 2024-05-22 Tax Withholding |
2024-05-23 9:54 pm |
N/A N/A |
Mereo BioPharma Group plc | MREO | Hughes-Wilson Alexandra See Remarks |
24,918 | $1.01 | 7,650 (Direct) |
View |
| 2024-05-22 Tax Withholding |
2024-05-23 9:54 pm |
N/A N/A |
Mereo BioPharma Group plc | MREO | Hughes-Wilson Alexandra See Remarks |
42,983 | $1.4 | 7,650 (Direct) |
View |
| 2024-05-22 Exercise |
2024-05-23 9:54 pm |
N/A 2032-01-14 |
Mereo BioPharma Group plc | MREO | Hughes-Wilson Alexandra See Remarks |
93,333 | $1.4 | 7,650 (Direct) |
View |
| 2024-02-08 Option Award |
2024-02-09 4:15 pm |
N/A 2034-02-08 |
Mereo BioPharma Group plc | MREO | Ekblom Anders Director |
64,471 | $0 | 64,471 (Direct) |
View |